Kamal Al Shawafi, MD

Modis c/o GSK, Belgium

Disclosure(s): Modis: I am an employee of Modis, working on behalf of the GSK group of companies

Poster(s):

• 114 - Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET